AU Patent

AU2017200907A1 — Semifluorinated alkane compositions

Assigned to Novaliq GmbH · Expires 2017-03-02 · 9y expired

What this patent protects

TITLE: SEMIFLUORINATED ALKANE COMPOSITIONS Abstract The invention provides novel compositions comprising semifluorinated alkanes and at least one compound sensitive or prone to oxidation. The compositions can be used as medicines that are topically administered to an eye or ophth…

USPTO Abstract

TITLE: SEMIFLUORINATED ALKANE COMPOSITIONS Abstract The invention provides novel compositions comprising semifluorinated alkanes and at least one compound sensitive or prone to oxidation. The compositions can be used as medicines that are topically administered to an eye or ophthalmic tissue. The invention further provides kits comprising such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017200907A1
Jurisdiction
AU
Classification
—
Expires
2017-03-02
Drug substance claim
No
Drug product claim
No
Assignee
Novaliq GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.